QRG CAPITAL MANAGEMENT, INC.

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1996454 BERWYN, PA

Position in UTHR

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,883,401

-$109,011 QoQ

Shares Held

3,476

+3.5% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#19

of 75 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	372,752	$5,975,214
2	ZTS	Zoetis Inc.	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp This page	3,476	$1,883,401
7	VTRS	Viatris Inc	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,883,401	3,476	+3.5%	Shares	Sole	2026-07-14
2026-03-31	$1,992,412	3,360	-28.4%	Shares	Sole	2026-04-27
2025-12-31	$2,285,202	4,690	+14.4%	Shares	Sole	2026-02-02
2025-09-30	$1,718,341	4,099	-76.9%	Shares	Sole	2025-10-28
2025-06-30	$5,106,209	17,770	+6.2%	Shares	Sole	2025-07-21
2025-03-31	$5,155,815	16,725	-1.4%	Shares	Sole	2025-04-17
2024-12-31	$5,988,047	16,971	+3.6%	Shares	Sole	2025-02-05
2024-09-30	$5,869,773	16,380	+6.9%	Shares	Sole	2024-10-30
2024-06-30	$4,880,504	15,321	+12.4%	Shares	Sole	2024-07-12
2024-03-31	$3,130,853	13,629	-2.6%	Shares	Sole	2024-05-07
2023-12-31	$3,076,700	13,992	+2.5%	Shares	Sole	2024-02-07
2023-09-30	$3,082,222	13,646	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.